Earnings Call · Q1 FY2022·2022-05-12

Q1 22EPS 0.00%·Rev n/aQ4 21EPS -14.29%·Rev n/aQ3 21EPS +37.50%·Rev n/aQ2 21EPS -100.00%*·Rev n/a⚠ consensus missing

ZEVRA THERAPEUTICS, INC. ZVRA

Jason Rando — Investor Relations / Host

Travis Mickle — Chief Executive Officer

LaDuane Clifton — Chief Financial Officer

−3.3%1d on move date−5.7% vs SPY3d+9.9%5d+20.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ZVRA calls or request research access.

More ZVRA calls Browse calls Request research access